Ketamine Hydrochloride

盐酸氯胺酮

Report date: 2026/05/21 20:00:22
NME

Base Information

Drug NameKetamine Hydrochloride
Drug Alias NameKetamina盐酸克他命盐酸织胺酮Ketaminum盐酸氯氨酮 +[21] 
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSedationCoronavirus Disease 2019 (COVID-19)Upper Limb Fracture +[79] 
Global Approved IndicationsAnesthesia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEndo International Plc
China Registration ClassN/A

Develop Information

Active CompaniesUtah State UniversityErp Biomarker Qualification ConsortiumThe Royal'S Institute Of Mental Health Research +[42] 
Inactive CompaniesAugusta UniversityHospiraDrexel University College of Medicine +[58] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Upper Limb FracturePost-Acute COVID-19 Syndrome +[41] 
Inactive IndicationsSedationSchizophreniaBorderline Personality Disorder +[38] 

Other Information

ATC CodeN01AX03
Related LinksWikipediaDrugBankKEGG